valproic acid has been researched along with Brain Diseases in 126 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (12.70) | 18.7374 |
1990's | 23 (18.25) | 18.2507 |
2000's | 29 (23.02) | 29.6817 |
2010's | 38 (30.16) | 24.3611 |
2020's | 20 (15.87) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Huang, H; Xu, Z | 1 |
Anthonipillai, P; Kimber, J; Sharp, G; Ziauddin, V | 1 |
Bryant, C; Chetwood, JD; Koorey, D | 1 |
Bloemkolk, D; Gerritse, FL; Rundervoort, RS; van Haaren, PCF | 1 |
Fang, Y; Fang, Z; Hui, L; Yu-E, Y; Zheng-Li, D; Zhi-Qin, L | 1 |
Liu, X; Peng, X | 1 |
Gupta, S; Sharma, DS; Sharma, P | 1 |
Beuchat, I; Loser, V; Novy, J; Rossetti, AO | 1 |
Arias-Vivas, E; Duat-Rodríguez, A; García-Peñas, JJ; González-Alguacil, E; Gutiérrez-Delicado, E; Heppe-Montero, M; Justel-Rodríguez, M; Ordoño-Saiz, MV; Púa-Torrejón, RC; Ruiz-Falcó-Rojas, ML; Soto-Insuga, V | 1 |
Abeysundera, H; Jeyaranjan, H; Ranjith, S | 1 |
Baumgartner, J; Fellinger, M; Frey, R; Friedrich, F; Graf, I; Hinterbuchinger, B; Hoeflich, A; Mossaheb, N | 1 |
Jiang, Z; Li, B; Li, J; Li, Y; Wang, L; Zhang, T | 1 |
Shah, S; Vieux, U; Wang, R | 1 |
Hodes, JF; Hu, XY; Lu, PL; Zheng, X | 1 |
Croom, JE; Fields, RK; Ilieva, HS; Newman, JW | 1 |
Fu, L; Li, SQ; Pei, W; Yu, Y | 1 |
Edquist, C; O'Rourke, N; Pagali, S | 1 |
Jing, W; Li, J; Tian, X; Wang, X; Wu, J | 1 |
Kazmierski, D; O'Leary, K; Ochieng, P; Sharma, N | 1 |
Chen, M; Lv, D; Yang, Y; Zhao, K | 1 |
Pellegrino, F; Tardivo, I | 1 |
Cherian, KA; Legatt, AD | 1 |
Chatterjee, SS; Das, R; Das, S; Mitra, S | 1 |
Abu Sitta, E; Gaddam, M; Kanzy, A; Velagapudi, RK | 1 |
Ceberio-Hualde, L; Cebrian-Novella, D; Diaz Alvarez-Mediavilla, J; Gomez-Del Olmo, V; Nava-Mateos, JJ; Roiz-Rey, P | 1 |
Avila-Cabreja, JA; Fernandez-Massip, H; Fornaris-Cedeno, Y; Sosa-Gonzalez, I | 1 |
Espínola-Nadurille, M; Oñate-Cadena, N; Pérez-Esparza, R; Ramírez-Bermúdez, J | 1 |
Camilleri, L | 1 |
Geer, K; Izadi Firouzabadi, L; Mead, P | 1 |
Arcos Sánchez, C; Montes Castro, N; Vicente Gordo, D; Viloria Alebesque, A | 1 |
Lucie, O; Nazir, F; Spilg, E | 1 |
Jo, YH; Kang, C; Kim, J; Kim, K; Kim, MA; Lee, JH; Lee, MJ; Lee, SH; Park, CJ; Rhee, JE | 1 |
Sendrowski, K; Sobaniec, P; Sobaniec, W; Sobaniec-Lotowska, ME | 1 |
Belze, O; Fusciardi, J; Pujol, A; Remérand, F | 1 |
Dubynin, VA; Malyshev, AV; Myasoedov, NF; Razumkina, EV | 1 |
Amanat, S; Hassan, Y; Shahbaz, N | 1 |
Dong, L; Ji, M; Jia, M; Qiu, L; Wu, J; Yang, J; Zhang, G; Zhang, M | 1 |
Budhdeo, S; Marquette, M; Rajagopal, V; Singh, D | 1 |
Larsen, EP; Ostergaard, JR | 1 |
Boletis, JN; Darema, M; Efthimiou, A; Marinaki, S; Melexopoulou, C; Skalioti, C; Zavos, G | 1 |
Balkovec, V; Rener-Primec, Z | 1 |
Christensen, J; Harbo, T; Prakash, S | 2 |
Ali, EH; Elgoly, AH; Hegazy, HG | 1 |
Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM | 1 |
Chen, X; Su, Z; Wu, Z; Ye, S; Zhu, D; Zhuge, G | 1 |
Al-sharefi, A; Bilous, R | 1 |
Hwang, JE; Jo, YH; Kim, K; Kim, MA; Lee, JH; Lee, MJ | 1 |
Dawson, LP; Hollander, YS; Lee, SJ | 1 |
Celebisoy, N; Ciftci, S; Deveci, E; Guler, A; Yuceyar, N | 1 |
Corsini, GP; Gandolfo, F; Monacelli, F; Odetti, P; Parodi, MN; Serafini, G | 1 |
Birur, B; Fargason, RE; Landry, KB; Patel, N | 1 |
Hronová, K; Klement, P; Pokorná, P; Šíma, M; Slanař, O; Tibboel, D; van den Anker, JN | 1 |
Chen, CY; Tsai, MF | 1 |
LaRoche, SM; Shivdat-Nanhoe, R | 1 |
Gynther, M; Isotalo, A; Laine, K; Leppänen, J; Malmioja, K; Peura, L; Rautio, J | 1 |
Chatterjee, R; Das, S; Guha, G; Hasmi, MA; Joardar, S | 1 |
Chu, K; Jung, KH; Kim, DW; Lee, SK; Lee, ST; Moon, HJ; Noh, Y | 1 |
Lainez, E; Macaya-Ruiz, A; Raspall-Chaure, M; Roig-Quilis, M; Salas-Puig, J; Toledo, M | 1 |
Chiarelli, F; Morgese, G; Trotta, D; Verrotti, A | 1 |
Yoshimura, K | 1 |
Sobaniec-Lotowska, ME | 2 |
Kimura, M; Suzuki, H | 2 |
Asztely, F; Eriksson, B; Lokrantz, CM; Rosén, I | 1 |
Fallgatter, AJ; Leonhard, C; Lesch, KP; Mössner, R; Reif, A | 1 |
Irwin, SA; Kimmel, RJ; Meyer, JM | 1 |
Cheung, E; Fung, CW; Wong, V | 1 |
Rehman, A; Zafar, S | 1 |
Thygesen, KS; Wolf, P | 1 |
Augspach-Hofmann, R; Bendl, C; Buesing, D; Fitzek, S; Gerstner, T; Goetze, G; Haensch, CA; Klostermann, W; Koenig, SA; Lippert, G; Longin, E; Macke, A; Mayer, G; Reuland, M; Scheid, B; Wenzel, D | 1 |
Andrade, DM; Del Campo, JM; Wennberg, R; Zumsteg, D | 1 |
Morrison, PF; Sankar, R; Shields, WD | 1 |
Cai, FC; Zhang, XP; Zhu, HX | 1 |
Blum, W; Byrd, JC; Chan, KK; Devine, H; Devine, SM; Grever, MR; Hackanson, B; Heerema, NA; Huynh, L; Kefauver, C; Klisovic, RB; Liu, S; Liu, Z; Lozanski, G; Marcucci, G; Murgo, A; Plass, C; Vukosavljevic, T | 1 |
Jedrzejczak, J; Kuncíková, M; Magureanu, S | 1 |
Modjtahedi, B; Xiong, GL | 1 |
Bauer, J | 1 |
Alvarez, F; Bruetman, JE; Finn, BC; Trimarchi, H; Young, P | 1 |
Allen, RJ; Coulter, DL | 1 |
Arnetoli, G; Boncinelli, L; Campostrini, R; Paganini, M; Zaccara, G; Zappoli, R | 1 |
Beckner, RR; Marini, AM; Passarelli, C; Wagle, W; Zaret, BS | 1 |
Axelgaard, G | 1 |
Apicella, P; De Giorgio, LA; Innocenti, F; Pettiná, G; Seghieri, G; Zolfanelli, F | 1 |
Aicardi, J; Alfonso, I; Archila, R; Cañizales, E; Duchowny, M; Papazian, O | 1 |
Averbuch-Heller, L; Ben-Hur, T; Reches, A | 1 |
Aihara, N; Ishikawa, T; Kamiya, K; Kanayama, M; Katano, H; Nagai, H; Yamashita, N | 1 |
Khan, EM; Puri, AS; Saraswat, VA; Sharma, BC | 1 |
Bourgeois, BF; Chez, MG; Knowles, WD; Pippenger, CE | 1 |
Bernard, G; Mattei, A; Paliard, P; Plauchu, G | 1 |
Hennessy, MJ; Wiles, CM | 1 |
Fukuzumi, A; Kuwahara, M; Nakai, H; Nishino, M; Shima, M; Yoshioka, A | 1 |
Sobaniec, W; Sobaniec-Lotowska, ME | 1 |
Garaizar, C; Lambarri, I; Martín, MA; Prats, JM; Sousa, T | 1 |
Aumaitre, O; Biousse, V; Bousser, MG; Fardeau, C; Godeau, P; Huong, DL; Lehoang, P; N'Guyen, N; Papo, T; Piette, JC | 1 |
Belmonte, A; Canapicchi, R; Casalini, C; Guerrini, R; Perucca, E | 1 |
Amano, T; Ichikawa, H; Kawabata, K; Kushiro, M; Makino, H; Nagake, Y; Wada, J | 1 |
Bräunig, P; Göbel, R; Görtzen, A | 1 |
Gaily, E; Granström, ML; Liukkonen, E | 1 |
Adèr, HJ; Beenen, LF; Heimans, JJ; Kasteleijn-Nolst Trenité, DG; Lindeboom, J; Snoek, FJ; Touw, DJ; van Alphen, HA | 1 |
Hamer, HM; Knake, S; Rosenow, F; Schomburg, U | 1 |
Hirata, K; Katayama, S; Miyamoto, M; Miyamoto, T | 1 |
Calvani, M; Guaitolini, C; Paolone, G; Parisi, G; Parisi, P | 1 |
Cuber, JC; Dumont, O; Dumortier, J; Guegen, L; Paliard, P; Plauchu, G; Scoazec, JY | 1 |
Temkin, NR | 1 |
Chen, WT; Liao, KK; Yen, DJ; Yu, HY | 1 |
Cawthon, DF; Caylor, LM; Kraemer, DL; Morgan, JD; Ojemann, LM; Vossler, DG; Wilensky, AJ | 1 |
Augustynowicz, A; Sobaniec, W; Sobaniec-Lotowska, M | 1 |
Cartlidge, NE; Chadwick, DW; Cumming, WJ; Livingstone, I | 1 |
Fahn, S | 1 |
Binnie, CD; de Beer-Pawlikowski, NK; Goedhart, DM; Gutter, T; Meijer, JW; Meinardi, H; Rowan, AJ; van der Geest, P | 1 |
Fukusako, T; Morimatsu, M; Nogaki, H; Yamamoto, K | 1 |
Kobayashi, Y; Kuhara, T; Matsumoto, I; Murakami, K; Nishida, N; Sugimoto, T | 1 |
Khoo, SH; Leyland, MJ | 1 |
Buffa, C; Gentile, S; Ravetti, C; Sacerdote, I | 1 |
Smith, DB | 1 |
Chowdhury, V; Gulati, P; Puri, V | 1 |
Bentsen, KD; Gram, L | 1 |
Gale, K | 1 |
Cornford, EM; Oldendorf, WH | 1 |
Wallace, SJ | 1 |
Goto, S; Ichikawa, M; Matsuyama, K; Miyazaki, C | 1 |
Gastaut, JL; Mege, JL | 1 |
Manni, R; Tartara, A | 1 |
Fukuyama, Y; Izumi, T; Osawa, M; Utsumi, H | 1 |
13 review(s) available for valproic acid and Brain Diseases
Article | Year |
---|---|
A potential cause of adolescent onset Dyke-Davidoff-Masson syndrome: A case report.
Topics: Brain Diseases; Carbamazepine; China; Chronic Disease; Female; Humans; Intellectual Disability; Magnetic Resonance Imaging; Prognosis; Recurrence; Risk Assessment; Seizures; Severity of Illness Index; Syndrome; Tomography, X-Ray Computed; Valproic Acid; Young Adult | 2019 |
Valproic acid-induced encephalopathy: A review of clinical features, risk factors, diagnosis, and treatment.
Topics: Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Risk Factors; Valproic Acid | 2021 |
Lesson of the month 1: Sodium valproate-induced encephalopathy.
Topics: Aged; Ammonia; Anticonvulsants; Brain Diseases; Carnitine; Consciousness Disorders; Epilepsy; Humans; Hyperammonemia; Male; Polypharmacy; Valproic Acid | 2018 |
Valproic acid-induced hyperammonemic encephalopathy in a full-term neonate: a brief review and case report.
Topics: Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Infant, Newborn; Seizures; Valproic Acid | 2017 |
Valproate-induced hyperammonemic encephalopathy.
Topics: Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Valproic Acid | 2002 |
[Organic manic disorder].
Topics: Bipolar Disorder; Brain Diseases; Carbamazepine; Clonazepam; Diagnostic and Statistical Manual of Mental Disorders; Humans; International Classification of Diseases; Lithium Carbonate; Valproic Acid | 2003 |
[Organic bipolar disorder].
Topics: Bipolar Disorder; Brain Diseases; Carbamazepine; Humans; International Classification of Diseases; Lithium Carbonate; Psychotropic Drugs; Valproic Acid | 2003 |
Susac syndrome.
Topics: Adult; Anti-Inflammatory Agents; Audiometry, Pure-Tone; Brain Diseases; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescein Angiography; GABA Agents; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Retinal Artery Occlusion; Syndrome; Valproic Acid | 1998 |
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.
Topics: Anticonvulsants; Brain Diseases; Brain Injuries; Carbamazepine; Controlled Clinical Trials as Topic; Diazepam; Epilepsy; Humans; Lorazepam; Models, Statistical; Phenobarbital; Phenytoin; Randomized Controlled Trials as Topic; Risk; Seizures; Treatment Outcome; Valproic Acid | 2001 |
Cognitive effects of antiepileptic drugs.
Topics: Anticonvulsants; Brain Diseases; Carbamazepine; Cognition; Drug Tolerance; Humans; Phenobarbital; Phenytoin; Valproic Acid | 1991 |
Valproate: an updated review.
Topics: Abnormalities, Drug-Induced; Brain Diseases; Chemical and Drug Induced Liver Injury; Coma; Dyskinesia, Drug-Induced; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Humans; Huntington Disease; Infant; Pancreatitis; Parkinson Disease; Seizures, Febrile; Spasms, Infantile; Status Epilepticus; Tremor; Trigeminal Neuralgia; Valproic Acid | 1985 |
Epilepsy and the blood-brain barrier.
Topics: Animals; Animals, Newborn; Anticonvulsants; Biological Transport; Biomechanical Phenomena; Blood Proteins; Blood-Brain Barrier; Brain; Brain Diseases; Capillaries; Capillary Permeability; Cerebrovascular Circulation; Epilepsy; Forecasting; Lipids; Mammals; Peptides; Seizures; Valproic Acid | 1986 |
Use of ethosuximide and valproate in the treatment of epilepsy.
Topics: Abnormalities, Drug-Induced; Brain Diseases; Drug Interactions; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Ethosuximide; Humans; Status Epilepticus; Succinimides; Trimethadione; Valproic Acid | 1986 |
4 trial(s) available for valproic acid and Brain Diseases
Article | Year |
---|---|
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Brain Diseases; Decitabine; Fatigue; Humans; Infections; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Remission Induction; Treatment Failure; Valproic Acid | 2007 |
An observational study of first-line valproate monotherapy in focal epilepsy.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Brain Diseases; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Epilepsies, Partial; Epilepsy; Female; Gastrointestinal Diseases; Humans; International Cooperation; Male; Middle Aged; Prospective Studies; Skin Diseases; Treatment Outcome; Valproic Acid; Weight Gain | 2008 |
Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
Topics: 4-Aminobutyrate Transaminase; Adrenocorticotropic Hormone; Anticonvulsants; Brain Diseases; Child; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Electroencephalography; Finland; gamma-Aminobutyric Acid; Humans; Incidence; Magnetic Resonance Imaging; Spasms, Infantile; Tomography, X-Ray Computed; Treatment Outcome; Valproic Acid; Videotape Recording; Vigabatrin | 1999 |
Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects.
Topics: Adult; Aged; Brain Diseases; Cognition; Craniotomy; Double-Blind Method; Epilepsy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Phenytoin; Quality of Life; Time Factors; Valproic Acid | 1999 |
109 other study(ies) available for valproic acid and Brain Diseases
Article | Year |
---|---|
Non-hyperammonaemia valproate-induced encephalopathy: A case report.
Topics: Anticonvulsants; Brain Diseases; Epilepsy; Female; Humans; Hyperammonemia; Middle Aged; Valproic Acid | 2022 |
Valproate-Associated Hyperammonaemic Encephalopathy.
Topics: Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Male; Middle Aged; Neurotoxicity Syndromes; Valproic Acid | 2022 |
Hyperammonaemic encephalopathy.
Topics: Brain Diseases; Humans; Neurotoxicity Syndromes; Valproic Acid | 2022 |
[A severe, reversible encephalopathy after prolonged use of valproic acid].
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Brain Diseases; Epilepsy; Female; Humans; Hyperammonemia; Valproic Acid | 2023 |
Valproate-induced hyperammonemic encephalopathy treated by L-ornithine-L-aspartate: a case report.
Topics: Ammonia; Anticonvulsants; Brain Diseases; Humans; Male; Middle Aged; Valproic Acid | 2023 |
Valproate-related hyperammonemic encephalopathy with generalized suppression EEG: a case report.
Topics: Adult; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Female; Humans; Hyperammonemia; Neurotoxicity Syndromes; Phenytoin; Valproic Acid | 2023 |
Valproate overdose leading to hyperammonaemic encephalopathy.
Topics: Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Male; Neurotoxicity Syndromes; Valproic Acid | 2023 |
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment.
Topics: Adult; Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Status Epilepticus; Valproic Acid | 2023 |
Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases.
Topics: Anticonvulsants; Brain; Brain Diseases; Cerebellum; Child; Child, Preschool; Epilepsy; Humans; Neurotoxicity Syndromes; Valproic Acid | 2023 |
Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.
Topics: Bipolar Disorder; Brain Diseases; Humans; Hyperammonemia; Male; Middle Aged; Neoplasm Recurrence, Local; Valproic Acid | 2023 |
Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy.
Topics: Adult; Anticonvulsants; Brain Diseases; Humans; Hyperammonemia; Male; Valproic Acid | 2019 |
Valproate-induced hyperammonemic encephalopathy: a case report.
Topics: Antimanic Agents; Brain Diseases; Confusion; Female; Gait Ataxia; Humans; Hyperammonemia; Middle Aged; Valproic Acid | 2020 |
Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
Topics: Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Causality; Corpus Callosum; Female; Headache; Humans; Levetiracetam; Male; Middle Aged; Paraspinal Muscles; Prognosis; Retrospective Studies; Seizures; Valproic Acid; Vertigo; Young Adult | 2020 |
Valproic acid and zonisamide induced hyperammonemic encephalopathy.
Topics: Adult; Anticonvulsants; Brain; Brain Diseases; Epilepsy; Humans; Hyperammonemia; Magnetic Resonance Imaging; Male; Valproic Acid; Zonisamide | 2020 |
Brain transcriptomics of nonhuman primates: A review.
Topics: Aging; Animals; Brain; Brain Diseases; Disease Models, Animal; Ethanol; Humans; Methamphetamine; Neurosciences; Primates; RNA-Seq; Sevoflurane; Transcriptome; Valproic Acid | 2021 |
Managing valproic acid toxicity-related hyperammonaemia: an unpredicted course.
Topics: Adult; Brain Diseases; Carnitine; Drug Overdose; Female; Humans; Hyperammonemia; Valproic Acid; Young Adult | 2021 |
Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency.
Topics: Adult; Brain Diseases; Humans; Hyperammonemia; Male; Ornithine Carbamoyltransferase Deficiency Disease; Seizures; Valproic Acid | 2021 |
Valproic-induced Hyperammonemic Encephalopathy Aggravated by Combined Use of Topiramate - A Case Report.
Topics: Anticonvulsants; Brain Diseases; Humans; Topiramate; Valproic Acid | 2021 |
SLC13A5-related epileptic encephalopathy successfully treated with valproate and acetazolamide.
Topics: Acetazolamide; Brain Diseases; Epilepsy, Generalized; Humans; Symporters; Valproic Acid | 2021 |
Burst Suppression Pattern on Electroencephalogram Secondary to Valproic Acid-Induced Hyperammonemic Encephalopathy.
Topics: Adolescent; Anticonvulsants; Autistic Disorder; Brain Diseases; Electroencephalography; Epilepsy; Female; Humans; Hyperammonemia; Valproic Acid | 2017 |
The damaged cortices and the uncontrolled Id: A case of post-measles hyper-sexuality.
Topics: Antipsychotic Agents; Brain; Brain Diseases; Child; Diagnosis, Differential; GABA Agents; Humans; Id; Male; Measles; Positron-Emission Tomography; Risperidone; Sexual Behavior; Valproic Acid | 2017 |
Two gaps too many, three clues too few? Do elevated osmolal and anion gaps with crystalluria always mean ethylene glycol poisoning?
Topics: Acid-Base Equilibrium; Acidosis; Anticonvulsants; Brain Diseases; Calcium Oxalate; Cognitive Dysfunction; Diagnosis, Differential; Epilepsy; Ethylene Glycol; Humans; Lactic Acid; Male; Medication Adherence; Middle Aged; Osmolar Concentration; Urolithiasis; Valproic Acid | 2017 |
[Treatment of encephalopathy by means of valproic acid with carglumic acid. Reply].
Topics: Anticonvulsants; Brain Diseases; Glutamates; Humans; Valproic Acid | 2018 |
[Treatment of encephalopathy by means of valproic acid with carglumic acid].
Topics: Anticonvulsants; Brain Diseases; Glutamates; Humans; Valproic Acid | 2018 |
Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
Topics: Adult; Anticonvulsants; Brain Diseases; Catatonia; Epilepsy; Female; Humans; Hyperammonemia; Valproic Acid; Young Adult | 2018 |
Severe hyperammonaemic encephalopathy resulting from the overlap between hepatic and valproate encephalopathy.
Topics: Alcoholism; Brain Diseases; Epilepsy; Humans; Hyperammonemia; Hypertension, Portal; Male; Middle Aged; Neurotoxicity Syndromes; Treatment Outcome; Valproic Acid; Withholding Treatment | 2018 |
Non-convulsive status epilepticus secondary to valproate-induced hyperammonaemic encephalopathy.
Topics: Anticonvulsants; Brain Diseases; Humans; Neurotoxicity Syndromes; Status Epilepticus; Valproic Acid | 2020 |
A case of valproate-induced hyperammonaemic encephalopathy.
Topics: Aged; Anticonvulsants; Brain Diseases; Female; Humans; Hyperammonemia; Valproic Acid | 2013 |
Effect of valproic acid on survival and neurologic outcomes in an asphyxial cardiac arrest model of rats.
Topics: Animals; Asphyxia; Brain Diseases; Disease Models, Animal; Enzyme Inhibitors; Heart Arrest; Male; Rats; Rats, Sprague-Dawley; Survival Rate; Valproic Acid | 2013 |
Ultrastructural study of hippocampal cortex neurons in an experimental model of valproate encephalopathy.
Topics: Animals; Brain Diseases; Cerebral Cortex; Cytoplasm; Disease Models, Animal; Hippocampus; Male; Neurons; Pyramidal Cells; Rats; Rats, Wistar; Valproic Acid | 2013 |
Hyperammonaemic encephalopathy and a flat electroencephalogram caused by valproic acid.
Topics: Adult; Anesthesia, General; Anticonvulsants; Brain Diseases; Craniocerebral Trauma; Electroencephalography; Epilepsy, Tonic-Clonic; Glasgow Coma Scale; Humans; Hyperammonemia; Hypnotics and Sedatives; Male; Midazolam; Valproic Acid | 2013 |
Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.
Topics: Adrenocorticotropic Hormone; Animals; Animals, Newborn; Anticonvulsants; Brain Diseases; Female; Male; Neuroprotective Agents; Peptide Fragments; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Valproic Acid | 2013 |
Valproic acid induced hyperammonaemic encephalopathy.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Child; Child, Preschool; Cohort Studies; Epilepsy; Female; Humans; Hyperammonemia; Male; Pakistan; Valproic Acid; Young Adult | 2013 |
Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy.
Topics: Animals; Brain Diseases; Brain-Derived Neurotrophic Factor; Carbazoles; Cecum; Cognition Disorders; Disease Models, Animal; Histone Deacetylase Inhibitors; Indole Alkaloids; Ligation; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Punctures; Receptor, trkB; Sepsis; Signal Transduction; Valproic Acid | 2013 |
Normoammonemic encephalopathy: solely valproate induced or multiple mechanisms?
Topics: Aged; Aggression; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Brain Diseases; Confusion; Delusions; Female; GABA Agents; Hallucinations; Humans; Migraine with Aura; Valproic Acid | 2014 |
Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
Topics: Adolescent; Anticonvulsants; Brain Diseases; Carnitine; Drug Therapy, Combination; Female; Humans; Hyperammonemia; Male; Neuronal Ceroid-Lipofuscinoses; Valproic Acid; Vitamin B Complex; Young Adult | 2014 |
Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
Topics: Adolescent; Anticonvulsants; Brain Diseases; Female; Humans; Hyperammonemia; Kidney Transplantation; Postoperative Complications; Valproic Acid | 2014 |
Valproate-related erythrodermia with reversible encephalopathy: a rare but serious adverse reaction, case report.
Topics: Anticonvulsants; Brain Diseases; Child, Preschool; Dermatitis, Exfoliative; Drug Eruptions; Humans; Male; Severity of Illness Index; Valproic Acid | 2014 |
[Valproate can induce reversible encephalopathy].
Topics: Aged; Anticonvulsants; Brain Diseases; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Valproic Acid | 2014 |
Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Autistic Disorder; Biomarkers; Brain; Brain Diseases; Chromatography, High Pressure Liquid; Female; Glutathione; Glutathione Disulfide; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; Mitochondria; Oxidative Stress; Parabens; Pregnancy; Rats, Wistar; Tumor Necrosis Factor-alpha; Tyrosine; Valproic Acid | 2015 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; Brain Mapping; Brain Neoplasms; Carnitine; Clobazam; Conscious Sedation; Consciousness Disorders; Craniotomy; Dominance, Cerebral; Frontal Lobe; Glioma; Humans; Hyperammonemia; Hypnotics and Sedatives; Intraoperative Complications; Language; Levetiracetam; Male; Middle Aged; Piperidines; Piracetam; Propofol; Remifentanil; Seizures; Temporal Lobe; Valproic Acid | 2015 |
[Clinical misdiagnosis analysis of valproate encephalopathy].
Topics: Anticonvulsants; Brain Diseases; Brain Edema; Brain Neoplasms; Diagnostic Errors; Epilepsy; Humans; Intracranial Hemorrhages; Valproic Acid; Vascular Diseases; Vasoconstriction | 2014 |
Reversible weakness and encephalopathy while on long-term valproate treatment due to carnitine deficiency.
Topics: Adult; Antimanic Agents; Brain Diseases; Cardiomyopathies; Carnitine; Female; Humans; Hyperammonemia; Muscle Weakness; Muscular Diseases; Psychotic Disorders; Treatment Outcome; Valproic Acid | 2015 |
Effect of valproic acid combined with therapeutic hypothermia on neurologic outcome in asphyxial cardiac arrest model of rats.
Topics: Animals; Asphyxia; Brain Diseases; Combined Modality Therapy; Disease Models, Animal; Enzyme Inhibitors; Heart Arrest; Hippocampus; Hypothermia, Induced; Male; Rats; Rats, Sprague-Dawley; Valproic Acid | 2015 |
[Valproate can induce reversible encephalopathy].
Topics: Aged; Anticonvulsants; Brain Diseases; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Valproic Acid | 2015 |
Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
Topics: Antimanic Agents; Bipolar Disorder; Brain Diseases; Humans; Hyperammonemia; Male; Middle Aged; Urinary Retention; Urinary Tract Infections; Valproic Acid | 2016 |
A case with hyperammonemic encephalopathy triggered by single dose valproate.
Topics: Attention Deficit Disorder with Hyperactivity; Brain Diseases; Female; GABA Agents; Humans; Hyperammonemia; Magnetic Resonance Imaging; Valproic Acid; Young Adult | 2016 |
Valproate-induced encephalopathy in a comorbid elderly woman.
Topics: Anticonvulsants; Brain Diseases; Comorbidity; Female; Humans; Hyperammonemia; Lethargy; Middle Aged; Polypharmacy; Psychotic Disorders; Valproic Acid | 2017 |
Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
Topics: Antimanic Agents; Bipolar Disorder; Brain Diseases; Female; Humans; Hyperammonemia; Middle Aged; Valproic Acid | 2017 |
Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
Topics: Adolescent; Anticonvulsants; Brain Diseases; Female; Humans; Hyperammonemia; Renal Dialysis; Valproic Acid | 2008 |
Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus.
Topics: Acetamides; Alcohol Withdrawal Seizures; Alcoholism; Anticonvulsants; Brain Diseases; Confusion; Diffusion Magnetic Resonance Imaging; Electroencephalography; Female; Humans; Lacosamide; Lorazepam; Middle Aged; Neurologic Examination; Paresis; Patient Compliance; Phenytoin; Seizures; Status Epilepticus; Tomography, X-Ray Computed; Valproic Acid | 2011 |
Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
Topics: Algorithms; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Diseases; Central Nervous System Agents; Drug Design; Drug Stability; Gas Chromatography-Mass Spectrometry; Infusions, Intra-Arterial; Isomerism; Large Neutral Amino Acid-Transporter 1; Male; Molecular Structure; Phenylalanine; Prodrugs; Rats; Spectrometry, Mass, Electrospray Ionization; Valproic Acid | 2011 |
Unilateral basal-ganglia involvement likely due to valproate-induced hyperammonemic encephalopathy.
Topics: Anticonvulsants; Basal Ganglia; Brain Diseases; Child, Preschool; Diffusion Magnetic Resonance Imaging; Functional Laterality; Humans; Hyperammonemia; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Seizures; Valproic Acid | 2012 |
Topiramate increases the risk of valproic acid-induced encephalopathy.
Topics: Adult; Aged; Anticonvulsants; Brain Diseases; Drug Interactions; Drug Therapy, Combination; Electroencephalography; Female; Fructose; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Topiramate; Valproic Acid; Young Adult | 2013 |
[Reversible encephalopathy caused by valproic acid in an adolescent with idiopathic generalised epilepsy].
Topics: Adolescent; Anticonvulsants; Brain Diseases; Epilepsy, Generalized; Humans; Male; Valproic Acid | 2012 |
A case of nonconvulsive status epilepticus associated with focal cortical dysplasia.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain Diseases; Cerebral Cortex; Child; Child, Preschool; Clobazam; Electroencephalography; Female; Humans; Infant; Magnetic Resonance Imaging; Pyridoxal Phosphate; Radiography; Status Epilepticus; Valproic Acid | 2003 |
Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.
Topics: Animals; Anticonvulsants; Astrocytes; Behavior, Animal; Brain Diseases; Male; Microscopy, Electron; Neocortex; Parahippocampal Gyrus; Rats; Rats, Wistar; Valproic Acid | 2003 |
Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam.
Topics: Aged; Amdinocillin Pivoxil; Anti-Bacterial Agents; Anticonvulsants; Brain Diseases; Female; Humans; Hyperammonemia; Valproic Acid | 2004 |
Encephalopathy and myoclonus triggered by valproic acid.
Topics: Adult; Antimanic Agents; Brain Diseases; Electroencephalography; Humans; Male; Myoclonus; Valproic Acid | 2004 |
Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
Topics: Antimanic Agents; Bipolar Disorder; Brain Diseases; Confusion; Female; Humans; Hyperammonemia; Middle Aged; Tremor; Unconsciousness; Valproic Acid | 2005 |
Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
Topics: Adolescent; Anticonvulsants; Brain Diseases; Chromosome Inversion; Chromosomes, Human, Pair 15; Drug Therapy, Combination; Epilepsy; Fructose; Humans; Hyperammonemia; Male; Syndrome; Topiramate; Valproic Acid | 2005 |
Valproate-induced encephalopathy.
Topics: Aged; Anticonvulsants; Brain Diseases; Electroencephalography; Female; Humans; Valproic Acid | 2005 |
[Valproate-caused encephalopathy].
Topics: Aged; Anticonvulsants; Brain Diseases; Humans; Male; Mental Status Schedule; Neurotoxicity Syndromes; Valproic Acid | 2005 |
Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
Topics: Adolescent; Aged; Anticonvulsants; Brain Diseases; Child, Preschool; Female; Humans; Hyperammonemia; Infant; Male; Middle Aged; Neurotoxicity Syndromes; Surveys and Questionnaires; Valproic Acid | 2006 |
Parietal lobe source localization and sensitivity to hyperventilation in a patient with subclinical rhythmic electrographic discharges of adults (SREDA).
Topics: Aged; Anticonvulsants; Brain Diseases; Electroencephalography; Humans; Hyperventilation; Magnetic Resonance Imaging; Male; Parietal Lobe; Valproic Acid | 2006 |
Valproate-induced chorea and encephalopathy in atypical nonketotic hyperglycinemia.
Topics: Anticonvulsants; Brain Diseases; Child; Chorea; Female; Humans; Hyperglycinemia, Nonketotic; Valproic Acid | 2006 |
[Experimental study on the possibility of brain damage induced by chronic treatment with phenobarbital, clonazepam, valproic acid and topiramate in immature rats].
Topics: Age Factors; Animals; Anticonvulsants; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Diseases; Clonazepam; Microscopy, Electron, Transmission; Neurons; Phenobarbital; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Valproic Acid | 2007 |
Hyperammonemia and valproic acid-induced encephalopathy.
Topics: Brain Diseases; Humans; Hyperammonemia; Protein Binding; Valproic Acid | 2007 |
Encephalopathy induced by levetiracetam added to valproate.
Topics: Adult; Anticonvulsants; Brain Diseases; Electroencephalography; Epilepsy; Humans; Levetiracetam; Male; Piracetam; Valproic Acid | 2008 |
[Valproate-associated hyperammonemic encephalopathy. Report of one case].
Topics: Aged; Anticonvulsants; Brain Diseases; Female; Humans; Hyperammonemia; Valproic Acid | 2007 |
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
Topics: Ammonia; Brain; Brain Diseases; Child, Preschool; Epilepsy; Female; Humans; Propionates; Valproic Acid | 1980 |
Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids.
Topics: Adolescent; Adult; Ammonia; Brain Diseases; Butyrates; Epilepsy; Fatty Acids; Female; Hemiterpenes; Humans; Isobutyrates; Male; Pentanoic Acids; Propionates; Reye Syndrome; Valerates; Valproic Acid | 1983 |
Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.
Topics: Adult; Ammonia; Brain Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Epilepsy, Temporal Lobe; Evoked Potentials; Female; Humans; Liver Function Tests; Male; Middle Aged; Valproic Acid | 1982 |
[Liver involvement and encephalopathy in a child during sodium valproate therapy].
Topics: Brain Diseases; Chemical and Drug Induced Liver Injury; Child, Preschool; Female; Humans; Valproic Acid | 1982 |
[Description of a case of a syndrome similar to Reye's syndrome in a male adult undergoing treatment with valproic acid and phenobarbital].
Topics: Adult; Brain Diseases; Coma; Epilepsy, Tonic-Clonic; Fever; Humans; Male; Muscle Rigidity; Phenobarbital; Reye Syndrome; Valproic Acid; Vomiting | 1982 |
Reversible dementia and apparent brain atrophy during valproate therapy.
Topics: Atrophy; Brain Diseases; Child; Child, Preschool; Dementia; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Male; Valproic Acid | 1995 |
Valproate encephalopathy and hypocarnitinaemia in diabetic patients.
Topics: Adolescent; Adult; Brain Diseases; Carnitine; Diabetes Mellitus, Type 1; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Valproic Acid | 1994 |
West syndrome associated with porencephaly.
Topics: Adrenocorticotropic Hormone; Brain Diseases; Child, Preschool; Clonazepam; Comorbidity; Cysts; Electroencephalography; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Nitrazepam; Spasms, Infantile; Treatment Outcome; Valproic Acid | 1994 |
Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
Topics: Adolescent; Brain Diseases; Drug Therapy, Combination; Fatal Outcome; Hepatic Encephalopathy; Humans; Jaundice; Liver; Male; Mannitol; Necrosis; Neomycin; Phenobarbital; Valproic Acid | 1994 |
Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice.
Topics: Animals; Brain; Brain Diseases; Drug Interactions; Drug Synergism; Electroshock; Epilepsy; Female; Mice; Phenytoin; Valproic Acid | 1994 |
[Encephalopathy associated with hyperammonemia in an alcoholic patient treated with sodium valproate].
Topics: Ammonia; Brain Diseases; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenobarbital; Psychoses, Alcoholic; Valproic Acid | 1993 |
Lamotrigine encephalopathy.
Topics: Anticonvulsants; Astrocytoma; Brain Diseases; Brain Neoplasms; Drug Interactions; Female; Frontal Lobe; Humans; Lamotrigine; Middle Aged; Seizures; Triazines; Valproic Acid | 1996 |
A case of West syndrome with atypical massive gray matter heterotopia that is well controlled by ACTH therapy.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Brain; Brain Diseases; Choristoma; Clonazepam; Drug Therapy, Combination; Electroencephalography; Female; Humans; Infant; Spasms, Infantile; Tomography, X-Ray Computed; Valproic Acid | 1996 |
Morphological features of encephalopathy after chronic administration of the antiepileptic drug valproate to rats. A transmission electron microscopic study of capillaries in the cerebellar cortex.
Topics: Animals; Brain Diseases; Capillaries; Cerebellum; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Microscopy, Electron; Neuroglia; Rats; Rats, Wistar; Valproic Acid | 1996 |
[Clinical workload at the outpatient neuropediatric clinic].
Topics: Adolescent; Ambulatory Care; Brain Diseases; Child; Child, Preschool; Electroencephalography; Female; Health Services; Humans; Incidence; Infant; Infant, Newborn; Information Systems; Male; Neurology; Pediatrics; Phenobarbital; Prevalence; Spain; Valproic Acid | 1997 |
Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.
Topics: Atrophy; Brain; Brain Diseases; Child; Cognition Disorders; Diagnosis, Differential; Electroencephalography; Epilepsy; Female; Humans; Intellectual Disability; Intelligence Tests; Magnetic Resonance Imaging; Prospective Studies; Retrospective Studies; Valproic Acid; Wechsler Scales | 1998 |
Fatal hyperammonemia in a patient with systemic lupus erythematosus.
Topics: Adult; Ammonia; Anticonvulsants; Brain Diseases; Fatal Outcome; Female; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Nephrotic Syndrome; Risk Factors; Seizures; Valproic Acid | 1998 |
[Encephalopathies caused by valproate].
Topics: Adult; Ammonia; Anticonvulsants; Brain Diseases; Drug Interactions; Epilepsy; Humans; Middle Aged; Valproic Acid | 1999 |
Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.
Topics: Adult; Ammonia; Anticonvulsants; Brain Diseases; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Fructose; Humans; Male; Topiramate; Valproic Acid | 2000 |
[A case report of valproate encephalopathy].
Topics: Adult; Ammonia; Anticonvulsants; Biomarkers; Brain; Brain Diseases; Carnitine; Epilepsy; Female; Humans; Mitochondria; Valproic Acid | 1999 |
Latent coeliac disease in a child with epilepsy, cerebral calcifications, drug-induced systemic lupus erythematosus and intestinal folic acid malabsorption associated with impairment of folic acid transport across the blood-brain barrier.
Topics: Adolescent; Anticonvulsants; Biological Transport; Blood-Brain Barrier; Brain; Brain Diseases; Calcinosis; Celiac Disease; Epilepsy; Ethosuximide; Folic Acid; Humans; Lupus Erythematosus, Systemic; Male; Urea; Valproic Acid | 2001 |
[Encephalopathy induced by ingestion of ammonium during valproate therapy].
Topics: Brain Diseases; Diet; Drug Interactions; Female; Humans; Hyperammonemia; Middle Aged; Quaternary Ammonium Compounds; Valproic Acid | 2001 |
Valproate-induced encephalopathy.
Topics: Ammonia; Anticonvulsants; Brain Diseases; Electroencephalography; Female; Humans; Middle Aged; Valproic Acid | 2001 |
Ultrastructure of Purkinje cell perikarya and their dendritic processes in the rat cerebellar cortex in experimental encephalopathy induced by chronic application of valproate.
Topics: Animals; Anticonvulsants; Brain Diseases; Cerebellar Cortex; Dendrites; Drug Administration Schedule; Male; Microscopy, Electron; Purkinje Cells; Rats; Rats, Wistar; Valproic Acid | 2001 |
Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.
Topics: Adolescent; Adult; Ammonia; Anticonvulsants; Brain; Brain Diseases; Electroencephalography; Female; Glutamine; Humans; Hyperammonemia; Male; Middle Aged; Valproic Acid | 2002 |
Morphometric analysis of the cerebellar cortex capillaries in the course of experimental valproate encephalopathy and after chronic exposure to sodium valproate using transmission electron microscopy.
Topics: Animals; Anticonvulsants; Brain Diseases; Capillaries; Cerebellar Cortex; Cerebrovascular Circulation; Male; Microscopy, Electron; Rats; Rats, Wistar; Valproic Acid | 2001 |
Acute intoxication with sodium valproate.
Topics: Acute Disease; Adolescent; Adult; Brain Diseases; Epilepsy; Female; Humans; Male; Valproic Acid | 1979 |
Posthypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen.
Topics: Adult; Brain Diseases; Estrogens, Conjugated (USP); Female; Humans; Hypoxia; Hypoxia, Brain; Male; Middle Aged; Myoclonus; Valproic Acid | 1979 |
Sodium valproate: serial monitoring of EEG and serum levels.
Topics: Adolescent; Adult; Brain Diseases; Electroencephalography; Female; Humans; Middle Aged; Seizures; Valproic Acid | 1979 |
[Multiple system atrophy with macro square wave jerks and pendular nystagmus].
Topics: Atrophy; Baclofen; Brain Diseases; Diazepam; Electrooculography; Eye Movements; Female; Humans; Middle Aged; Nystagmus, Pathologic; Phenobarbital; Saccades; Valproic Acid | 1992 |
Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy.
Topics: Brain Diseases; Carnitine; Cerebral Palsy; Child; Chronic Disease; Female; Gas Chromatography-Mass Spectrometry; Humans; Oxidation-Reduction; Seizures; Valproic Acid | 1992 |
Cerebral edema following acute sodium valproate overdose.
Topics: Adult; Brain Diseases; Drug Overdose; Edema; Humans; Hypocalcemia; Kidney; Liver; Male; Valproic Acid | 1992 |
State of stupor from valproic acid during chronic treatment: case report.
Topics: Adult; Brain Diseases; Carbamazepine; Clonazepam; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Unconsciousness; Valproic Acid | 1991 |
Myoclonus: a manifestation of neurocysticercosis.
Topics: Brain Diseases; Child; Cysticercosis; Female; Humans; Myoclonus; Praziquantel; Valproic Acid | 1991 |
Role of the substantia nigra in GABA-mediated anticonvulsant actions.
Topics: Aminocaproates; Aminooxyacetic Acid; Animals; Anticonvulsants; Brain; Brain Diseases; Denervation; Disease Susceptibility; Efferent Pathways; gamma-Aminobutyric Acid; Humans; Injections; Mesencephalon; Nerve Endings; Nerve Tissue Proteins; Reaction Time; Seizures; Substantia Nigra; Synaptic Transmission; Valproic Acid; Vigabatrin | 1986 |
Effect of sodium valproate (VPA) on cerebral amino acids: mechanism of gamma-aminobutyric acid (GABA) elevation and possible causal relation of VPA-induced encephalopathy and glutamine level.
Topics: Amino Acids; Animals; Brain Chemistry; Brain Diseases; gamma-Aminobutyric Acid; Glutamine; Male; Mice; Mice, Inbred Strains; Valproic Acid | 1988 |
[Encephalopathy with asterixis induced by sodium valproate. Role of hyperammonemia without hepatic insufficiency].
Topics: Ammonia; Brain Diseases; Humans; Male; Middle Aged; Movement Disorders; Valproic Acid | 1985 |
Sodium valproate "encephalopathy": report of three cases with generalised epilepsy.
Topics: Adult; Arousal; Brain Diseases; Child; Confusion; Electroencephalography; Epilepsy; Female; Humans; Male; Valproic Acid | 1985 |
[A clinico-biochemical study of acute encephalopathy in patients treated with Ca-hopantenate].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Blood Chemical Analysis; Brain Diseases; Child; Child, Preschool; Female; gamma-Aminobutyric Acid; Humans; Infant; Male; Pantothenic Acid; Reye Syndrome; Valproic Acid | 1985 |